Price History
Feb 9, 2026 — May 24, 2026Investment Snapshot
- P/B of 59.59 — trading above book value
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- Loss-making — negative ROE of -58.4%
- Revenue declining 17% annually
Ingevity Corporation Common Stock (NGVT) is a Basic Materials company operating in Chemicals & Allied Products, listed on the NYSE , with a market capitalisation of $2.3 billion . Key value metrics: P/B ratio 59.59, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Ingevity Corporation Common Stock — Fundamental Analysis Summary
On financial health, NGVT shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and negative return on equity of -58.4% (sector average: -1.2%), and high leverage with a debt-to-equity ratio of 6.86.
StockPik's composite Value Score for NGVT is 47/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
NGVT reports a solid gross margin of 40.4% (sector average: 33.0%) and a strong operating margin of 33.8%.
NGVT shows revenue declining at 17% year-over-year, with earnings growing at 61%.